In an integrated audit of internal control over financial reporting and the financial statements, the auditor also may use this work to obtain evidence supporting the auditor's assessment of control risk for purposes of the audit of the financial statements.
A new development in uveitis treatment during the past few years is the increased use of tumor necrosis alpha (TNF-Î±) inhibitors, specifically infliximab (Remicade, Janssen Biotech Inc.) and adalimumab (Humira, Abbott Laboratories).
A group of drugs called prostaglandin analogs are used to treat glaucoma by increasing fluid drainage. Three different medications of this type are marketed as glaucoma treatment: Travatan (generic name travoprost), Lumigan (generic name bimatoprost) and Xalatan (generic name latanaprost). This class of ophthalmic solution may cause the common side effects of burning or stinging.